IWWM-11 2022 | Novel FHL2 G226A mutation identified in familial Waldenström’s macroglobulinemia
Yike Wan
• 25 Oct 2022
Yike Wan, MD, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China, briefly summarizes a study which used germline DNA exome sequencing to identify a novel FHL2 G226A mutation as a genetic variant that may contribute to familial cases of Waldenström’s macroglobulinemia (WM), and further highlights the importance of conducting genomic studies in this disease. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
